{"schema_version":"secwatch.filing_event.v1","accession":"0000109380-21-000216","form_type":"8-K","ticker":"ZION","cik":"0000109380","company_name":"ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/","filed_at":"2021-07-19T23:59:59+00:00","discovered_at":"2026-05-14T18:04:17.132792+00:00","generated_at":"2026-06-30T04:22:54.639201+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Zions Q2 net earnings $345M, diluted EPS $2.08 vs $0.34 YoY; credit release of $123M","bullets":["Net earnings $345M ($2.08 diluted EPS) vs $57M ($0.34) in Q2 2020; PPNR up 32%.","Provision for credit losses negative $123M (release) vs positive $168M YoY; allowance 1.2% of loans ex-PPP.","CET1 capital ratio 11.3% vs 10.2% at pandemic start; preferred stock redemption of $126M.","Loans and leases $51.4B, down 7% (ex-PPP down 3%); deposits up 16% to $76.1B.","SBIC investment in Recursion Pharma contributed $54M net unrealized gain ($0.25 per share)."],"urls":{"canonical":"https://secwatch.observer/filing/0000109380-21-000216","json":"https://secwatch.observer/filing/0000109380-21-000216.json","markdown":"https://secwatch.observer/filing/0000109380-21-000216.md","text":"https://secwatch.observer/filing/0000109380-21-000216.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/109380/000010938021000216/0000109380-21-000216-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/109380/000010938021000216/zion-20210719.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-30T04:22:54.639201+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}